The 23 references in paper S. AL-SHUKRI H., S. BOROVETS Yu., V. DUBINSKYI ya., R. ZASEEV D., С. АЛЬ-ШУКРИ Х., С. БОРОВЕЦ Ю., В. ДУБИНСКИЙ Я., Р. ЗАССЕЕВ Д. (2011) “РЕЗУЛЬТАТЫ ИЗОЛИРОВАННОГО И КОМБИНИРОВАННОГО ПРИМЕНЕНИЯ HIFU-ТЕРАПИИ РАКА ПРЕДСТАТЕЛЬНОЙ ЖЕЛЕЗЫ (обзор литературы) // RESULTS OF PROSTATE CARCINOMA HIFU-THERAPY ISOLATED AND COMBINED APPLICATION (literature review)” / spz:neicon:nefr:y:2011:i:3:p:40-44

1
Петров СБ, Велиев ЕИ. Хирургическое лечение локализованных форм рака предстательной железы. Практическая онкология 2001; 6(2): 50–52
(check this in PDF content)
2
Петров СБ, Велиев ЕИ. Опыт лечения эректильной дисфункции у больных после радикальной простатэктомии Андрология и генитальная хирургия 2000; 1: 62–63
(check this in PDF content)
3
Велиев ЕИ, Петров СБ. Рак предстательной железы: диагностика и результаты хирургического лечения локализованных и местнораспространенных форм. Рус мед журн 2001; 9(13–14): 564–567
(check this in PDF content)
4
Павлов АС, Костромина КН, Симакина ЕП. Лучевая терапия в лечении рака предстательной железы. Матер Пленума правления Российского общества урологов. М., 1999: 149–153
(check this in PDF content)
5
Zeitman AL, Coen JJ, Shipley WU. Radical radiation Therapy in the management of prostate adenocarcinoma: the initial prostate specific antigen value as a predictor of treatment outcome. J Urol 1994; 151(2): 640–645
(check this in PDF content)
6
Chauvenic L, Flam Т, Servois V, N Guyen D, Rosenwald JC. Prostatic brachytherapy: an alternative therapy. Review of the literature. Cancer Radiother 2000; 4(4): 253–264
(check this in PDF content)
7
Zisman A, Leibovich D, Siegel YI. Prostate crioablation without an insertion kit using direct transperineal placement of ultrathin freezing probes. Techniq Urol 2000; 6(1): 34–36
(check this in PDF content)
8
Zisman A, Pantuck AJ, Cohen JK, Belldegrun AS. Prostate cryoablation using direct transperineal placement of ultrathin probes through a 17-gauge brachytherapy template – technique and preliminary results. Urology 2001; 58(4): 988–993
(check this in PDF content)
9
Kiel HJ, Wieland WF, Rossler W. Local control of prostate cancer by transrectal HIFU-therapy. Arch Ital Urol Androl 2000; 72(4): 313-319
(check this in PDF content)
10
Misrai V, Roupret M, Chartier-Kastler E, Comperat E et al. Oncologic control provided by HIFU therapy as single treatment in men with clinically localized prostate cancer. World J Urol 2008; 26 (5): 481-485
(check this in PDF content)
11
Poissonnier L, Gelet A, Chapelon JY, Bouvier R et al. Results of transrectal focused ultrasound for the treatment of localized prostate cancer. Prog Urol 2003; 13(1): 60-72
(check this in PDF content)
12
Uchida T, Sanghvi NT, Gardner TA, Koch MO et al. Transrectal high-intensity focused ultrasound for treatment of patients with stage T1b-N0M0 localized prostate cancer: a preliminary report. Urology 2002; 59(3): 394-399
(check this in PDF content)
13
Gelet A, Chapelon JY, Bouvier R, Rouviere O et al. Transrectal high-intensity focused ultrasound: minimally invasive therapy of localized prostate cancer. J Endourol 2000;
(check this in PDF content)
14
6): 519-528 14. Chaussy CG, Thuroff S. High-intensive focused ultrasound in localized prostate cancer. J Endourol 2000; 14(3): 293-299
(check this in PDF content)
15
Muto S, Yoshii T, Saito K, Kamiyama Y et al. Focal therapy with high-intensity-focused ultrasound in the treatment of localized prostate cancer. Jpn J Clin Oncol 2008; 38(3): 192-199
(check this in PDF content)
16
Uchida T, Ohkusa H, Yamashita H, Shoji S et al. Five years experience of transrectal high-intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancer. Int J Urol 2006; 13(3): 228-233
(check this in PDF content)
17
Ganzer R, Rogenhofer S, Walter B, Lunz JC. PSA nadir is a significant predictor of treatment failure after high-intensity focussed ultrasound (HIFU) treatment of localised prostate cancer. Eur Urol 2008; 53(3): 547-553
(check this in PDF content)
18
Lee HM, Hong JH, Choi HY. High-intensity focused ultrasound therapy for clinically localized prostate cancer. Prostate Cancer Prostatic Dis 2006; 9(4):439-443
(check this in PDF content)
19
Poissonnier L, Chapelon JY, Rouviиre O, Curiel L. Control of prostate cancer by transrectal HIFU in 227 patients. Eur Urol
(check this in PDF content)
20
7; 51(2): 381-387 20. Zacharakis E, Ahmed HU, Ishaq A, Scott R et al. The feasibility and safety of high-intensity focused ultrasound as salvage therapy for recurrent prostate cancer following external beam radiotherapy. BJU Int 2008; 102(7): 786-792
(check this in PDF content)
21
Chaussy C, Thuroff S. The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection. Curr Urol Rep 2003; 4(3): 248-252
(check this in PDF content)
22
Uchida T, Illing RO, Cathcart PJ, Emberton M. The effect of neoadjuvant androgen suppression on prostate cancerrelated outcomes after high-intensity focused ultrasound therapy. BJU Int 2006; 98(4):770-772
(check this in PDF content)
23
Lu J, Chen ZY, Wang W, Zhang YF. Transrectal highintensity focused ultrasound with the Sonablate 500 for the treatment of prostate cancer. Zhonghua Nan Ke Xue 2007; 13(11): 1005-1008 Ïîñòóïèëà â ðåäàêöèþ 21.02.2011 ã.
(check this in PDF content)